
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-08-19 | Judy Chu(D-CA28) | house | Purchase | $100,001 - $250,000 |
| 2025-08-19 | Judy Chu(D-CA28) | house | Sale | $100,001 - $250,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $28.3M+85.8% | $15.2M+64.7% | $9.2M+49.9% | $6.2M-5.7% | $6.5M |
| Cost of services, excluding depreciation and amortization | $2.84B+61.1% | $1.76B+50.5% | $1.17B+24.0% | $944.7M+58.5% | $596.1M |
| General and administrative expenses | $217.3M+41.0% | $154.1M+36.9% | $112.6M+45.0% | $77.7M+25.1% | $62.1M |
| Depreciation and amortization | $45.7M+63.8% | $27.9M+57.4% | $17.7M+1.2% | $17.5M+0.1% | $17.5M |
| Total expenses | $3.10B+59.5% | $1.95B+49.4% | $1.30B+25.2% | $1.04B+53.9% | $675.7M |
| Income from operations | $78.5M-12.1% | $89.3M+5.6% | $84.6M-18.8% | $104.3M+6.2% | $98.2M |
| Income from equity method investments | $1.7M-61.6% | $4.5M-20.2% | $5.6M-0.8% | $5.6M | — |
| Interest expense | -$49.9M-50.9% | -$33.1M-105.5% | -$16.1M-103.3% | -$7.9M-46.8% | -$5.4M |
| Interest income | $12.2M-16.2% | $14.5M+2.1% | $14.2M+619.0% | $2.0M+25.8% | $1.6M |
| Unrealized (loss) gain on investments | -$68K-109.3% | $731K+116.0% | -$4.6M | — | — |
| Other (loss) income | -$2.8M-157.2% | $4.9M-20.4% | $6.1M | — | — |
| Total other (expense) income, net | -$38.9M-356.2% | -$8.5M-263.3% | $5.2M+129.6% | -$17.6M | — |
| Income before provision for income taxes | $39.6M-51.0% | $80.8M-10.0% | $89.8M+3.7% | $86.6M+11.4% | $77.7M |
| Provision for income taxes | $15.5M-49.7% | $30.9M-3.4% | $32.0M-21.7% | $40.9M+29.0% | $31.7M |
| Net income | $24.1M-51.8% | $49.9M-13.7% | $57.8M+26.5% | $45.7M-0.7% | $46.1M |
| Net income (loss) attributable to noncontrolling interests | $1.6M-76.6% | $6.8M+336.5% | -$2.9M-603.2% | $570K | — |
| Net income attributable to Astrana Health, Inc. | $22.5M-47.9% | $43.1M-28.9% | $60.7M+34.4% | $45.2M-34.5% | $68.9M |
| Earnings per share - basic (in dollars per share) | $460-49.5% | $910-30.0% | $1K | — | — |
| Earnings per share – diluted (in dollars per share) | $460-48.9% | $900-30.2% | $1K+30.3% | $990-34.9% | $2K |
| Capitation, net | |||||
| Total revenue | $28.3M+85.8% | $15.2M+64.7% | $9.2M+49.9% | $6.2M-5.7% | $6.5M |
| Risk pool settlements and incentives | |||||
| Total revenue | $28.3M+85.8% | $15.2M+64.7% | $9.2M+49.9% | $6.2M-5.7% | $6.5M |
| Management fee income | |||||
| Total revenue | $28.3M+85.8% | $15.2M+64.7% | $9.2M+49.9% | $6.2M-5.7% | $6.5M |
| Fee-for-service, net | |||||
| Total revenue | $28.3M+85.8% | $15.2M+64.7% | $9.2M+49.9% | $6.2M-5.7% | $6.5M |
| Other revenue | |||||
| Total revenue | $28.3M+85.8% | $15.2M+64.7% | $9.2M+49.9% | $6.2M-5.7% | $6.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Assessing Astrana Health (ASTH) Valuation After Rapid Market Share And Revenue Growth
2 Profitable Stocks on Our Watchlist and 1 Facing Headwinds
How Investors Are Reacting To Astrana Health (ASTH) Surging Value-Based Care Revenue And Earnings
1 Healthcare Stock to Target This Week and 2 We Ignore